FDA NDC Directory · JSON-LD · Markdown

Simulect

NDC 0078-0331 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic namebasiliximab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA103764
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsBASILIXIMAB (20 mg/5mL)
Marketing started19980512
Package count1

External sources

Source: openFDA. Public-domain (CC0).